BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunleavy K, Little RF, Wilson WH. Update on Burkitt Lymphoma. Hematol Oncol Clin North Am 2016;30:1333-43. [PMID: 27888884 DOI: 10.1016/j.hoc.2016.07.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Gopal S, Gross TG. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 2018;132:254-63. [PMID: 29769263 DOI: 10.1182/blood-2018-04-844472] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
2 Della Rocca AM, Leonart LP, Ferreira VL, Tonin FS, Steffenello-Durigon G, Del Moral JAG, Fernandez-Llimos F, Pontarolo R. Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies. Clin Lymphoma Myeloma Leuk 2021;21:514-25. [PMID: 33947633 DOI: 10.1016/j.clml.2021.03.012] [Reference Citation Analysis]
3 Zhang Y, Li J, Zhong H, Xiao X, Wang Z, Cheng Z, Hu C, Zhang G, Liu S. The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis. Cell Death Discov 2021;7:268. [PMID: 34588425 DOI: 10.1038/s41420-021-00655-1] [Reference Citation Analysis]
4 Khan A, Brahim A, Ruiz M, Nagovski N. Relapsed/refractory Burkitt lymphoma and HIV infection. Int J STD AIDS 2018;29:695-703. [PMID: 29264956 DOI: 10.1177/0956462417748239] [Reference Citation Analysis]
5 Aguayo F, Boccardo E, Corvalán A, Calaf GM, Blanco R. Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer. Infect Agent Cancer 2021;16:50. [PMID: 34193233 DOI: 10.1186/s13027-021-00391-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Azimi N, Razmara F, Derakhshan S, Kardouni Khoozestani N. Mandibular sporadic Burkitt lymphoma in an adult patient: A case report and review of the literature. Clin Case Rep 2021;9:e04535. [PMID: 34306703 DOI: 10.1002/ccr3.4535] [Reference Citation Analysis]
7 Onaindia A, Santiago-Quispe N, Iglesias-Martinez E, Romero-Abrio C. Molecular Update and Evolving Classification of Large B-Cell Lymphoma. Cancers (Basel) 2021;13:3352. [PMID: 34283060 DOI: 10.3390/cancers13133352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Della Rocca AM, Tonin FS, Fachi MM, Cobre AF, Ferreira VL, Leonart LP, Steffenello-Durigon G, Del Moral JAG, Lenzi L, Pontarolo R. Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia. Diseases 2021;9:43. [PMID: 34203748 DOI: 10.3390/diseases9020043] [Reference Citation Analysis]
9 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Gozzi F, Cimino L, Masia F, Moretti M, Foroni M, De Marco L, Pellegrini D, De Raeve H, Ricci S, Tamagnini I, Tafuni A, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3). Cancers (Basel) 2021;13:6021. [PMID: 34885131 DOI: 10.3390/cancers13236021] [Reference Citation Analysis]
10 Virdis P, Marchesi I, Fiorentino FP, Migheli R, Sanna L, Bordoni V, Pintore G, Galleri G, Muroni MR, Bagella L, Fozza C, De Miglio MR, Podda L. Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes. Life (Basel) 2021;11:1128. [PMID: 34833004 DOI: 10.3390/life11111128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dillon M, Lopez A, Lin E, Sales D, Perets R, Jain P. Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers. Cancers (Basel) 2021;13:5059. [PMID: 34680208 DOI: 10.3390/cancers13205059] [Reference Citation Analysis]
12 Xie Y, Jia M, Shi J, Tao Y. Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma. Cancer Med 2020;9:3107-14. [PMID: 32160410 DOI: 10.1002/cam4.2975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Hu T, Gao Y. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway. Biomed Pharmacother 2018;106:1557-62. [PMID: 30119230 DOI: 10.1016/j.biopha.2018.07.124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Lin Y, Pan YH, Li MK, Zong XD, Pan XM, Tan SY, Guo YW. Clinical presentation of gastric Burkitt lymphoma presenting with paraplegia and acute pancreatitis: A case report. World J Gastroenterol 2021; 27(45): 7844-7854 [PMID: 34963746 DOI: 10.3748/wjg.v27.i45.7844] [Reference Citation Analysis]
15 Alderuccio JP, Lossos IS. DA-EPOCH-R for Adult Burkitt's Lymphoma: Pros and Cons. J Oncol Pract 2018;14:676-8. [PMID: 30423268 DOI: 10.1200/JOP.18.00624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Liu Y, Bian T, Zhang Y, Zheng Y, Zhang J, Zhou X, Xie J. A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma. Diagn Pathol 2019;14:100. [PMID: 31484540 DOI: 10.1186/s13000-019-0876-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Atallah-Yunes SA, Murphy DJ, Noy A. HIV-associated Burkitt lymphoma. Lancet Haematol 2020;7:e594-600. [PMID: 32735838 DOI: 10.1016/S2352-3026(20)30126-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
18 Saleh K, Michot JM, Camara-Clayette V, Vassetsky Y, Ribrag V. Burkitt and Burkitt-Like Lymphomas: a Systematic Review. Curr Oncol Rep 2020;22:33. [PMID: 32144513 DOI: 10.1007/s11912-020-0898-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Dunleavy K. Approach to the Diagnosis and Treatment of Adult Burkitt's Lymphoma. JOP 2018;14:665-71. [DOI: 10.1200/jop.18.00148] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
20 Cabras M, Arduino PG, Chiusa L, Broccoletti R, Carbone M. Case Report: Sporadic Burkitt lymphoma misdiagnosed as dental abscess in a 15-year-old girl. F1000Res 2018;7:1567. [PMID: 32117562 DOI: 10.12688/f1000research.16390.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Yang P, Dong F, Zhou Q. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway. Toxicology Letters 2017;278:9-17. [DOI: 10.1016/j.toxlet.2017.06.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
22 Bleckmann A, Dierks S, Schildhaus HU, Hellige N, Bacher U, Trümper L, Wulf G. Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation. Ann Hematol 2021;100:277-9. [PMID: 32193631 DOI: 10.1007/s00277-020-03974-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chavarriaga J, Arenas J, Medina M, Meek E, Perez J, Fernandez N. Do not Forget Burkitt´s Lymphoma! Unusual Case of Primary Malignant Lymphoma of the Prostate in a Young Patient. Urology 2020;138:152-5. [PMID: 31870928 DOI: 10.1016/j.urology.2019.12.011] [Reference Citation Analysis]
24 Stepniak A, Czuczwar P, Szkodziak P, Wozniakowska E, Wozniak S, Paszkowski T. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature. Arch Gynecol Obstet 2017;296:653-60. [PMID: 28770352 DOI: 10.1007/s00404-017-4478-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
25 Volaric AK, Singh K, Gru AA. Rare EBV-associated B cell neoplasms of the gastrointestinal tract. Semin Diagn Pathol 2021;38:38-45. [PMID: 33985830 DOI: 10.1053/j.semdp.2021.04.004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Alsharif R, Dunleavy K. Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements. Hematology/Oncology Clinics of North America 2019;33:587-96. [DOI: 10.1016/j.hoc.2019.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Kong J, Wang L, Ren L, Yan Y, Cheng Y, Huang Z, Shen F. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression. Toxicology and Applied Pharmacology 2018;342:1-13. [DOI: 10.1016/j.taap.2018.01.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
28 Zhen Z, Zhu J, Wang J, Lu S, Sun F, Huang J, Sun X. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4. Pediatric Hematology and Oncology 2020;37:489-99. [DOI: 10.1080/08880018.2020.1759741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Yang D, Wang P, Chen J, Li CX, Zhang Y, Chen XC, Wu DP. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2018;39:645-9. [PMID: 30180465 DOI: 10.3760/cma.j.issn.0253-2727.2018.08.007] [Reference Citation Analysis]
30 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Valle L, Ricci S, Gozzi F, Cimino L, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2). Cancers (Basel) 2021;13:4527. [PMID: 34572754 DOI: 10.3390/cancers13184527] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]